Share
Share today's newsletter with a colleague
and get credit if they sign up for SmartBrief.
Referral Count:
0
Story being shared
Health Canada approves skin cancer device from Sensus
Health Canada has given Sensus Healthcare the go-ahead to market its SRT-100 system in that country. The device, tailored for use in hospitals and private physician practices, is designed to treat patients with non-melanoma skin cancer without the need for surgery.
Or we can send an email on your behalf